Page last updated: 2024-11-03

propranolol and Obesity

propranolol has been researched along with Obesity in 113 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
"Anti-obesity effects of calcium antagonists such as benidipine and nifedipine have been described in rodent obesity models, but the mode of action of the calcium antagonists as anti-obesity agents has not been established."7.70Benidipine induces thermogenesis in brown adipose tissue by releasing endogenous noradrenaline: a possible mechanism for the anti-obesity effect of calcium antagonists. ( Bengtsson, T; Cannon, B; Golozoubova, V; Nedergaard, J; Zhao, J, 1999)
" A reduction of body weight was seen and urinary glucose excretion, increase in body temperature, reduction in maximal plasma glucose and insulin levels in the oral glucose tolerance test, and stimulation of glucose transport into skeletal muscle and adipose tissue, were completely attenuated by the non-specific β-AR antagonist propranolol."3.78Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG). ( Russell, ST; Tisdale, MJ, 2012)
" This bradycardia was blocked by atropine."3.74Parasympathetic response to acute stress is attenuated in young Zucker obese rats. ( Brown, DR; El-Wazir, YM; Li, SG; Randall, DC; Silcox, DL; Smith, R, 2008)
"Anti-obesity effects of calcium antagonists such as benidipine and nifedipine have been described in rodent obesity models, but the mode of action of the calcium antagonists as anti-obesity agents has not been established."3.70Benidipine induces thermogenesis in brown adipose tissue by releasing endogenous noradrenaline: a possible mechanism for the anti-obesity effect of calcium antagonists. ( Bengtsson, T; Cannon, B; Golozoubova, V; Nedergaard, J; Zhao, J, 1999)
" The metabolic response of lean and obese women to caffeine was studied to see if caffeine could be used to demonstrate the subnormal thermogenesis in obesity previously shown after standard meals or intravenous infusions of noradrenaline."3.66Caffeine: its effect on catecholamines and metabolism in lean and obese humans. ( Barrand, MA; Callingham, BA; James, WP; Jung, RT; Shetty, PS, 1981)
"Propranolol is a lipophilic drug so it was predicted that the pharmacokinetics would differ between obese and ideal-weight individuals."3.01A comparative evaluation of propranolol pharmacokinetics in obese versus ideal weight individuals: A blueprint towards a personalised medicine. ( Bertoldi, A; De Rubis, G; Dua, K; El Mekkawi, Z; Ho, A; Kakuzada, L; Mortlock, R; Nesci, I; Pont, L; Smith, V; Williams, K, 2023)
"The lipophilic beta-adrenoreceptor antagonist propranolol and hydrophilic atenolol have been studied to define their pharmacokinetic and pharmacodynamic characteristics in obese patients."2.71Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects. ( Droździk, M; Gawrońska-Szklarz, B; Jaroszynska, M; Pawlik, A; Sterna, R; Wójcicki, J, 2003)
"The pharmacokinetic data for the three drugs were qualitatively similar."2.68Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers. ( Carrupt, PA; Cheymol, G; Levron, JC; Poirier, JM; Snoeck, E; Testa, B; Weissenburger, J, 1997)
" Pharmacokinetic parameters were compared with those obtained previously in non-obese control subjects."2.67Comparison of propranolol and sotalol pharmacokinetics in obese subjects. ( Barré, J; Cheymol, G; Cohen, A; Hugues, FC; Le Jeunne, C; Poirier, JM, 1990)
"Propranolol treatment did not modify obesogenic effect of HFD feeding."1.46Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice. ( Brum, PC; Carneiro, EM; da Silva Franco, N; Davel, AP; Guizoni, DM; Lubaczeuski, C; Santos-Silva, JC; Victorio, JA, 2017)
" Chronic dosing of propranolol may be required for efficacy; therefore, we tested the efficacy of chronic treatment with either propranolol or phenytoin on RTT mice."1.42Treatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs. ( Glaze, DG; Herrera, JA; Kaufmann, WE; Neul, JL; Percy, AK; Pitcher, MR; Skinner, S; Ward, CS; Wehrens, XH, 2015)
"Obesity is associated with endothelial dysfunction and inflammation."1.35Use of fat-fed rats to study the metabolic and vascular sequelae of obesity and beta-adrenergic antagonism. ( Fagan, K; Frye, M; McMurtry, I; Orton, EC, 2009)
" Dose-response curves with epinephrine from lean mice were best fit to a two-component model comprised of 23% high affinity (K(act) = 1."1.29Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. ( Collins, S; Daniel, KW; Gettys, TW; Ramkumar, V; Rohlfs, EM; Taylor, IL, 1994)
"Predisposition to obesity has been suggested to be related to a low energy expenditure (EE)."1.29[Effect of 3-month exercise training on daily energy expenditure in formerly obese women with reduced and stable weight]. ( Astrup, AV; Buemann, B, 1993)
" Dose-response curves show similar sensitivity, but decreased responsiveness in the lean animal."1.28Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists. ( Bray, GA; Tsujii, S, 1992)
" In obese subjects the pharmacokinetic data calculated for sotalol (total clearance (CL), volume of distribution (V beta), half-life of elimination (t1/2), were comparable with those measured in the controls."1.28[Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects]. ( Cheymol, G, 1990)
"Diazepam binding was slightly decreased in the obese as a result of lower serum albumin concentrations and elevated free fatty acids."1.27Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects. ( Benedek, IH; Blouin, RA; McNamara, PJ, 1984)
" Elimination half-life was similar for the two populations (3."1.27Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers. ( Barre, J; Cheymol, G; Dry, J; Poirier, JM; Pradalier, A, 1987)
" After intravenous administration there was no difference in plasma clearance but the volume of distribution was greater (V = 339 l vs 198 l) and the half-life was longer (t1/2 = 5."1.27A comparison of the pharmacokinetics of propranolol in obese and normal volunteers. ( Bowman, SL; Clements, JA; Hudson, SA; Munro, JF; Simpson, G, 1986)
"Obesity is a circumstance characterized in the dog fat cell by a modification of the balance between alpha-2 and beta receptors."1.26Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization. ( Berlan, M; Carpene, C; Dang-Tran, L; Lafontan, M, 1982)
"Ephedrine is a potential slimming drug that stimulates thermogenesis in man and laboratory animals."1.26Ephedrine, a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta-adrenoreceptors. ( Bukowiecki, L; Follea, N; Jahjah, L, 1982)

Research

Studies (113)

TimeframeStudies, this research(%)All Research%
pre-199062 (54.87)18.7374
1990's22 (19.47)18.2507
2000's13 (11.50)29.6817
2010's14 (12.39)24.3611
2020's2 (1.77)2.80

Authors

AuthorsStudies
Xie, F1
Yang, F1
Liang, Y1
Li, L1
Xia, Y1
Jiang, F1
Liu, W1
Qi, Y1
Chowdhury, SR1
Xie, D1
Fu, L1
Narayanan, S1
Wang, S1
Vasukuttan, V1
Vyas Devambatla, RK1
Dai, D1
Jin, C1
Snyder, R1
Laudermilk, L1
Runyon, SP1
Maitra, R1
Mortlock, R1
Smith, V1
Nesci, I1
Bertoldi, A1
Ho, A1
El Mekkawi, Z1
Kakuzada, L1
Williams, K1
Pont, L1
De Rubis, G1
Dua, K1
da Silva Franco, N1
Lubaczeuski, C1
Guizoni, DM1
Victorio, JA1
Santos-Silva, JC1
Brum, PC1
Carneiro, EM1
Davel, AP1
Baek, K2
Kang, J1
Lee, J1
Kim, M1
Baek, JH2
Park, D1
Hwang, HR1
Kim, SG1
Lee, H1
Matsumura, S1
Ishikawa, F1
Sasaki, T1
Odanaka, M1
Manio, MCC1
Fushiki, T1
Inoue, K1
Fitzgerald, PJ1
Molobe, LT1
Shifa, J1
Silava, C1
Mojela, K1
Cainelli, F1
Vento, S1
Herrera, JA1
Ward, CS1
Pitcher, MR1
Percy, AK1
Skinner, S1
Kaufmann, WE1
Glaze, DG1
Wehrens, XH1
Neul, JL1
Diong, C1
Jones, PP1
Tsuchimochi, H1
Gray, EA1
Hughes, G1
Inagaki, T1
Bussey, CT1
Fujii, Y1
Umetani, K1
Shirai, M1
Schwenke, DO1
El-Wazir, YM1
Li, SG1
Smith, R1
Silcox, DL1
Brown, DR1
Randall, DC1
Ormsbee, MJ1
Choi, MD1
Medlin, JK1
Geyer, GH1
Trantham, LH1
Dubis, GS1
Hickner, RC1
Hattori, A1
Mawatari, K1
Tsuzuki, S1
Yoshioka, E1
Toda, S1
Yoshida, M1
Yasui, S1
Furukawa, H1
Morishima, M1
Ono, K1
Ohnishi, T1
Nakano, M1
Harada, N1
Takahashi, A1
Nakaya, Y1
Belza, A1
Gille, MB1
Schultz John, S1
Kondrup, J1
Frye, M1
McMurtry, I1
Orton, EC1
Fagan, K1
An, S1
Han, JI1
Kim, MJ1
Park, JS1
Han, JM1
Baek, NI1
Chung, HG1
Choi, MS1
Lee, KT1
Jeong, TS1
Russell, ST2
Tisdale, MJ2
Mirbolooki, MR1
Constantinescu, CC1
Pan, ML1
Mukherjee, J1
Wójcicki, J1
Jaroszynska, M1
Droździk, M1
Pawlik, A1
Gawrońska-Szklarz, B1
Sterna, R1
Lennon, JA1
Brech, WJ1
Gordon, ES1
Jung, RT3
Shetty, PS3
James, WP4
Arch, JR2
Ainsworth, AT1
Berlan, M4
Dang-Tran, L2
Lafontan, M5
Denard, Y1
Stein, PM1
Hassanein, RS1
Lukert, BP1
Carpene, C2
Bukowiecki, L1
Jahjah, L1
Follea, N1
Yen, TT1
McKee, MM1
Stamm, NB1
Bemis, KG1
Wilson, S1
Thurlby, PL1
Benedek, IH2
Blouin, RA2
McNamara, PJ2
Inoue, S1
Mullen, YS1
Bray, GA3
Rothwell, NJ3
Stock, MJ3
Fiske, WD1
Griffen, WO1
Bell, RM1
Hervey, GR1
Tobin, G1
Lieberman, E1
Dieterlen, P1
Desjeux, JF1
Giraud, M1
Villard, S1
Lestradet, H1
Barrand, MA1
Callingham, BA1
Atkinson, RL1
Dahms, WT1
Sperling, MA1
Ahrén, B1
Lundquist, I1
Saville, ME1
McCrory, WW1
Uza, G1
Pavel, O1
Uza, D1
Vlaicu, R1
Yoshida, T1
Sakane, N1
Wakabayashi, Y1
Yoshioka, K1
Umekawa, T1
Kondo, M1
Bégin-Heick, N2
Van Vliet, BN2
Hall, JE1
Mizelle, HL1
Montani, JP2
Smith, MJ1
Collins, S1
Daniel, KW1
Rohlfs, EM1
Ramkumar, V1
Taylor, IL1
Gettys, TW1
Buemann, B2
Astrup, AV1
Piccirillo, G1
Vetta, F1
Fimognari, FL1
Ronzoni, S1
Lama, J1
Cacciafesta, M1
Marigliano, V1
Kuo, CH1
Ding, Z1
Ivy, JL1
Cheymol, G4
Poirier, JM3
Carrupt, PA1
Testa, B1
Weissenburger, J1
Levron, JC1
Snoeck, E1
Zhao, J1
Golozoubova, V1
Bengtsson, T1
Cannon, B1
Nedergaard, J1
Paolisso, G1
Manzella, D1
Tagliamonte, MR1
Rizzo, MR1
Gambardella, A1
Varricchio, M1
Flechtner-Mors, M1
Ditschuneit, HH1
Yip, I1
Adler, G1
Berger, JJ1
Barnard, RJ1
Antic, V1
Kiener-Belforti, F1
Tempini, A1
Børsheim, E1
Lönnroth, P1
Knardahl, S1
Jansson, PA1
Getty, L1
Panteleon, AE1
Mittelman, SD1
Dea, MK1
Bergman, RN1
Picard, F1
Richard, D1
Timofeeva, E1
Deshaies, Y1
Seematter, G1
Guenat, E1
Schneiter, P1
Cayeux, C1
Jéquier, E1
Tappy, L1
van Aggel-Leijssen, DP1
Saris, WH1
Hul, GB1
van Baak, MA1
Galitzky, J2
Sengenès, C1
Thalamas, C1
Marques, MA1
Senard, JM1
Stepp, DW1
Frisbee, JC1
Saitta, A1
Quartarone, M1
Cucinotta, D1
Mangano, C1
Pizzoleo, MA1
Squadrito, G2
Burns, TW2
Terry, BE2
Langley, PE2
Robison, GA2
Boyer, PA1
O'rourke, RA1
Schnitzler, RN1
Barbarine, A1
De Marinis, L1
Troncone, L1
Bernasconi, S1
Giovannelli, G1
Andler, W1
Olefsky, J2
Crapo, PA1
Ginsberg, H1
Reaven, GM2
Hickler, RB1
Cabezas-Cerrato, J1
Mur, AL1
Aranguren, LV1
Vila, T1
Fernández-Cruz, A1
Cugini, P1
Giovannini, C1
Rossi, G1
Sellini, M1
Sartori, MP1
Tsujii, S1
Astrup, A1
Madsen, J1
Christensen, NJ1
Saad, MF1
Alger, SA1
Zurlo, F1
Young, JB1
Bogardus, C2
Ravussin, E2
Le Feuvre, RA1
Woods, AJ1
Riviere, D1
Foureau, M1
Tran, MA1
Flores, R1
Louvet, JP1
Houin, G1
Le Jeunne, C1
Cohen, A1
Barré, J2
Hugues, FC1
Bürgi, U1
Bürgi-Saville, ME1
Burgherr, J1
Clément, M1
Lauber, K1
Skołuda, A1
Kozłowska, F1
Paradowski, S1
Gracz, M1
Rebourcet, MC1
Guichard, C1
Lavau, M1
York, DA3
Holt, SJ3
Marchington, D2
Welsh, J1
Pradalier, A1
Dry, J1
Grzywa, M1
Wheal, HV1
Bowman, SL1
Hudson, SA1
Simpson, G1
Munro, JF1
Clements, JA1
Zed, C1
Simon, J1
Leclercq, B1
Schwartz, RS1
Robbins, DC1
Wolfe, RR1
Horton, ES1
Danforth, E1
Sims, EA1
Allars, J1
Lotti, G1
Delitala, G1
Masala, A1
Tempero, KF1
Olefsky, JM1
Farquhar, JW2
Atkins, T1
Matty, AJ1
Tulloch, BR1
Vydelingum, N1
Galton, DJ1
Laube, H1
Fussgänger, RD1
Pfeiffer, EF1
Robertson, RP1
Porte, D1
Reaven, G1
Carducci Artenisio, A1
Sprovieri, M1
Albanese, MC1
Allegra, V1
Ragonese, F1
Corsi, V1
Rath, R1
Kujalová, V1
Veselková, A1
Balestreri, R1
Bertolini, S1
Elicio, N1
Vandeweghe, M1
Vermeulen, A1
Cranston, WI1
Parra, A1
Schultz, RB1
Kato, Y1
Morimoto, M1
Imura, H1
Herrold, JN1
Tzagournis, M1
Hammerl, H1
Kränzl, C1
Köhn, H1
Nebosis, G1
Pichler, O1
Studlar, M1
Kühns, K1
Wettich, JE1
Samwer, KF1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Resistance Training Modulation of Fat Metabolism in Obese Postmenopausal Women[NCT05351476]120 participants (Anticipated)Interventional2022-05-20Recruiting
Phase I, Open-Label Study to Evaluate Potential Pharmacokinetic of Orally Administered Oseltamivir in Healthy Obese Thai Adult Subjects[NCT01049763]Phase 124 participants (Actual)Interventional2010-01-31Completed
Influence of Walking on Spontaneous Physical Activity and on Lipid Oxidation Following Dietary Treatment of Obesity[NCT00775970]20 participants (Anticipated)Interventional2008-05-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

5 reviews available for propranolol and Obesity

ArticleYear
A comparative evaluation of propranolol pharmacokinetics in obese versus ideal weight individuals: A blueprint towards a personalised medicine.
    Chemico-biological interactions, 2023, Feb-01, Volume: 371

    Topics: Half-Life; Humans; Kinetics; Obesity; Precision Medicine; Propranolol

2023
The part played by variation of energy expenditure in the regulation of energy balance.
    The Proceedings of the Nutrition Society, 1982, Volume: 41, Issue:2

    Topics: Animals; Body Composition; Body Weight; Calorimetry, Indirect; Diet; Dietary Fats; Energy Intake; En

1982
Blood pressure and primary hypertension in childhood and adolescence.
    Current problems in pediatrics, 1980, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Antihypertensive Agents; Blood Pressure Determination; Cardiovascular Diseases; C

1980
Angina pectoris: diagnosis, evaluation and therapy.
    Geriatrics, 1973, Volume: 28, Issue:11

    Topics: Angina Pectoris; Angiography; Digitalis Glycosides; Ethanol; Female; Heart Function Tests; Humans; M

1973
Advances in medicine.
    The Practitioner, 1968, Volume: 201, Issue:204

    Topics: Acute Kidney Injury; Asthma; Blindness; Catecholamines; Contraceptives, Oral; Coronary Disease; Guan

1968

Trials

10 trials available for propranolol and Obesity

ArticleYear
The beta-adrenergic antagonist propranolol partly abolishes thermogenic response to bioactive food ingredients.
    Metabolism: clinical and experimental, 2009, Volume: 58, Issue:8

    Topics: Adrenergic beta-Antagonists; Adult; Basal Metabolism; Blood Pressure; Caffeine; Capsaicin; Catechin;

2009
Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
    Biopharmaceutics & drug disposition, 2003, Volume: 24, Issue:5

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Area Under Curve; Atenolol; Blood Pressure

2003
The effect of beta-adrenergic blockade on metabolic rate and peripheral thyroid metabolism in obesity.
    European journal of clinical investigation, 1980, Volume: 10, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Basal Metabolism; Catecholamines; Diet, Reducing; Female; Humans

1980
Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.
    British journal of clinical pharmacology, 1997, Volume: 43, Issue:6

    Topics: Adipose Tissue; Adrenergic beta-Antagonists; Adult; Area Under Curve; Benzopyrans; Binding Sites; Bi

1997
Sympathetic modulation of lipolysis in subcutaneous adipose tissue: effects of gender and energy restriction.
    The Journal of laboratory and clinical medicine, 1999, Volume: 134, Issue:1

    Topics: Abdomen; Adipose Tissue; Adrenergic Agents; Adult; Energy Intake; Epinephrine; Female; Glycerol; Hum

1999
Effects of mental stress on insulin-mediated glucose metabolism and energy expenditure in lean and obese women.
    American journal of physiology. Endocrinology and metabolism, 2000, Volume: 279, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiac Output; Energy Metabolism; Epinephrine;

2000
Short-term effects of weight loss with or without low-intensity exercise training on fat metabolism in obese men.
    The American journal of clinical nutrition, 2001, Volume: 73, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Diet, Reducing; Energy Intake; Exercise; F

2001
A 24-h energy expenditure study on reduced-obese and nonobese women: effect of beta-blockade.
    The American journal of clinical nutrition, 1992, Volume: 56, Issue:4

    Topics: Adult; Blood Glucose; Body Composition; Body Mass Index; Carbohydrate Metabolism; Energy Metabolism;

1992
Comparison of propranolol and sotalol pharmacokinetics in obese subjects.
    The Journal of pharmacy and pharmacology, 1990, Volume: 42, Issue:5

    Topics: Adult; Blood Pressure; Cardiac Output; Chromatography, High Pressure Liquid; Creatinine; Female; Hea

1990
Metabolic response to simultaneous infusion of epinephrine and propranolol in obese adolescents.
    Metabolism: clinical and experimental, 1969, Volume: 18, Issue:6

    Topics: Adolescent; Blood Glucose; Clinical Trials as Topic; Drug Synergism; Epinephrine; Fatty Acids, Nones

1969

Other Studies

98 other studies available for propranolol and Obesity

ArticleYear
Investigation of stereoisomeric bisarylethenesulfonic acid esters for discovering potent and selective PTP1B inhibitors.
    European journal of medicinal chemistry, 2019, Feb-15, Volume: 164

    Topics: Animals; Antigens, CD; Cell Membrane Permeability; Diabetes Mellitus, Type 2; Esters; Glucose; Human

2019
Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice.
    Journal of medicinal chemistry, 2021, 03-25, Volume: 64, Issue:6

    Topics: Animals; Apelin Receptors; Humans; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Pyra

2021
Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice.
    Pharmacological research, 2017, Volume: 122

    Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Diet, High-Fat; Endot

2017
The Time Point-Specific Effect of Beta-Adrenergic Blockade in Attenuating High Fat Diet-Induced Obesity and Bone Loss.
    Calcified tissue international, 2018, Volume: 103, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Bone and Bones; Bone Density; Bone Diseases, Meta

2018
Blocking β₁/β₂-Adrenergic Signaling Reduces Dietary Fat Absorption by Suppressing Expression of Pancreatic Lipase in High Fat-Fed Mice.
    International journal of molecular sciences, 2018, Mar-14, Volume: 19, Issue:3

    Topics: Acinar Cells; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Cyclic AMP Response Element-Binding

2018
Voluntary Corn Oil Ingestion Increases Energy Expenditure and Interscapular UCP1 Expression Through the Sympathetic Nerve in C57BL/6 Mice.
    Molecular nutrition & food research, 2018, Volume: 62, Issue:22

    Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Corn Oil; Energy Intake; Energy Metabol

2018
Is elevated norepinephrine an etiological factor in some cases of Parkinson's disease?
    Medical hypotheses, 2014, Volume: 82, Issue:4

    Topics: Animals; Antidepressive Agents; Bipolar Disorder; Disease Progression; Humans; Mice; Models, Theoret

2014
Primary pseudotumor cerebri syndrome in a young obese African woman.
    The Israel Medical Association journal : IMAJ, 2014, Volume: 16, Issue:9

    Topics: Acetazolamide; Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Antihypertensive Agents; Diuretic

2014
Treatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs.
    Disease models & mechanisms, 2015, Volume: 8, Issue:4

    Topics: Adrenergic beta-Antagonists; Animals; Anticonvulsants; Arrhythmias, Cardiac; Disease Models, Animal;

2015
Sympathetic hyper-excitation in obesity and pulmonary hypertension: physiological relevance to the 'obesity paradox'.
    International journal of obesity (2005), 2016, Volume: 40, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Lung

2016
Parasympathetic response to acute stress is attenuated in young Zucker obese rats.
    Autonomic neuroscience : basic & clinical, 2008, Dec-05, Volume: 143, Issue:1-2

    Topics: Adrenergic beta-Antagonists; Animals; Atropine; Blood Pressure; Body Weight; Bradycardia; Conditioni

2008
Regulation of fat metabolism during resistance exercise in sedentary lean and obese men.
    Journal of applied physiology (Bethesda, Md. : 1985), 2009, Volume: 106, Issue:5

    Topics: Adipose Tissue; Adult; Body Mass Index; Energy Metabolism; Exercise; Exercise Test; Glycerol; Humans

2009
Beta-adrenergic-AMPK pathway phosphorylates acetyl-CoA carboxylase in a high-epinephrine rat model, SPORTS.
    Obesity (Silver Spring, Md.), 2010, Volume: 18, Issue:1

    Topics: Acetyl-CoA Carboxylase; Adrenergic beta-Antagonists; AMP-Activated Protein Kinases; Analysis of Vari

2010
Use of fat-fed rats to study the metabolic and vascular sequelae of obesity and beta-adrenergic antagonism.
    Comparative medicine, 2009, Volume: 59, Issue:3

    Topics: Acetylcholine; Adrenergic beta-Antagonists; Animals; Blood Flow Velocity; Body Weight; Cytokines; Di

2009
Ethanolic extracts of Brassica campestris spp. rapa roots prevent high-fat diet-induced obesity via beta(3)-adrenergic regulation of white adipocyte lipolytic activity.
    Journal of medicinal food, 2010, Volume: 13, Issue:2

    Topics: Adipocytes, White; Adrenergic Agents; Animals; Anti-Obesity Agents; Brassica; Cyclic AMP-Dependent P

2010
Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG).
    Biochimica et biophysica acta, 2012, Volume: 1821, Issue:4

    Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Blood Glucose; Blotting, Western; Body Weight;

2012
Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG).
    Endocrinology, 2012, Volume: 153, Issue:10

    Topics: Adipocytes; Administration, Oral; Adrenergic beta-Antagonists; Animals; Body Temperature; Body Weigh

2012
Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity.
    Synapse (New York, N.Y.), 2013, Volume: 67, Issue:2

    Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxeti

2013
Effect of a short period of cold exposure on plasma FFA level in lean and obese humans.
    Metabolism: clinical and experimental, 1967, Volume: 16, Issue:6

    Topics: Blood Glucose; Cold Temperature; Fasting; Fatty Acids; Fatty Acids, Nonesterified; Female; Humans; M

1967
Thermogenic and antiobesity activity of a novel beta-adrenoceptor agonist (BRL 26830A) in mice and rats.
    The American journal of clinical nutrition, 1983, Volume: 38, Issue:4

    Topics: Adrenergic beta-Agonists; Animals; Body Composition; Body Temperature Regulation; Body Weight; Energ

1983
Influence of hypocaloric diet on alpha-adrenergic responsiveness of obese human subcutaneous adipocytes.
    International journal of obesity, 1981, Volume: 5, Issue:2

    Topics: Adipose Tissue; Adolescent; Adult; Diet, Reducing; Energy Intake; Epinephrine; Female; Glucose Toler

1981
Predicting weight loss success among obese clients in a hospital nutrition clinic.
    The American journal of clinical nutrition, 1981, Volume: 34, Issue:10

    Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care Facilities; Body Weight; Estrogens, Conjugated

1981
Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1982, Volume: 14, Issue:5

    Topics: Adipose Tissue; Animals; Clonidine; Dogs; Epinephrine; Isoproterenol; Lipolysis; Obesity; Prazosin;

1982
Ephedrine, a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta-adrenoreceptors.
    International journal of obesity, 1982, Volume: 6, Issue:4

    Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Cells, Cultured; Dose-Response Relation

1982
Stimulation of cyclic AMP and lipolysis in adipose tissue of normal and obese Avy/a mice by LY79771, a phenethanolamine, and stereoisomers.
    Life sciences, 1983, Mar-28, Volume: 32, Issue:13

    Topics: 2-Hydroxyphenethylamine; Adipose Tissue; Animals; Cyclic AMP; Fatty Acids, Nonesterified; Lipolysis;

1983
Genetically obese C57BL/6 ob/ob mice respond normally to sympathomimetic compounds.
    Life sciences, 1984, Sep-17, Volume: 35, Issue:12

    Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Energy Metabolism; Ephedrine; Ethanolam

1984
Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects.
    British journal of clinical pharmacology, 1984, Volume: 18, Issue:6

    Topics: Adolescent; Adult; Blood Proteins; Diazepam; Humans; Lipids; Lipoproteins; Male; Obesity; Orosomucoi

1984
Hyperinsulinemia in rats with hypothalamic obesity: effects of autonomic drugs and glucose.
    The American journal of physiology, 1983, Volume: 245, Issue:3

    Topics: Animals; Atropine; Epinephrine; Female; Glucose; Hyperinsulinism; Isoproterenol; Obesity; Phentolami

1983
Acute effects of fat and carbohydrate on metabolic rate in normal, cold-acclimated and lean and obese (fa/fa) Zucker rats.
    Metabolism: clinical and experimental, 1983, Volume: 32, Issue:4

    Topics: Acclimatization; Adipose Tissue, Brown; Animals; Atropine; Body Temperature Regulation; Cold Tempera

1983
Serum alpha 1-acid glycoprotein and the binding of drugs in obesity.
    British journal of clinical pharmacology, 1983, Volume: 16, Issue:6

    Topics: Adult; Blood Proteins; Diazepam; Female; Humans; Obesity; Orosomucoid; Propranolol; Protein Binding

1983
[Measurement of insulin sensitivity in obese or diabetic children in vivo. A comparison of three methods (author's transl)].
    Archives francaises de pediatrie, 1980, Volume: 37 Suppl 2

    Topics: Adolescent; Blood Glucose; C-Peptide; Child; Diabetes Mellitus; Epinephrine; Glucose; Humans; Insuli

1980
Caffeine: its effect on catecholamines and metabolism in lean and obese humans.
    Clinical science (London, England : 1979), 1981, Volume: 60, Issue:5

    Topics: Adult; Blood Glucose; Body Temperature Regulation; Caffeine; Catecholamines; Fatty Acids, Nonesterif

1981
Adrenergic modulation of glucagon and insulin secretion in obese and lean humans.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1981, Volume: 13, Issue:5

    Topics: Adult; Blood Glucose; Epinephrine; Glucagon; Humans; Insulin; Insulin Secretion; Obesity; Phentolami

1981
Modulation of basal insulin secretion in the obese, hyperglycemic mouse.
    Metabolism: clinical and experimental, 1982, Volume: 31, Issue:2

    Topics: Animals; Atropine Derivatives; Blood Glucose; Insulin; Mannoheptulose; Mice; Mice, Obese; Obesity; P

1982
Factors influencing the acute effect of food on oxygen consumption in the rat.
    International journal of obesity, 1982, Volume: 6, Issue:1

    Topics: Adaptation, Physiological; Animals; Cold Temperature; Eating; Energy Metabolism; Feeding Behavior; M

1982
Essential hypertension in childhood.
    Pediatric annals, 1982, Volume: 11, Issue:7

    Topics: Adolescent; Child; Diet, Sodium-Restricted; Electrocardiography; Humans; Hydrochlorothiazide; Hypert

1982
Effect of propranolol on hypophosphatemia in overweight.
    International journal of obesity, 1982, Volume: 6, Issue:5

    Topics: Adult; Blood Pressure; Electrolytes; Female; Humans; Male; Middle Aged; Obesity; Phosphates; Propran

1982
The alpha/beta-adrenergic receptor blocker arotinolol activates the thermogenesis of brown adipose tissue in monosodium-L-glutamate-induced obese mice.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1994, Volume: 18, Issue:5

    Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; An

1994
Beta 3-adrenergic activation of adenylyl cyclase in mouse white adipocytes: modulation by GTP and effect of obesity.
    Journal of cellular biochemistry, 1995, Volume: 58, Issue:4

    Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Adipocytes; Adipose Tissue; Adrenergic beta-Agonists; Al

1995
Reduced parasympathetic control of heart rate in obese dogs.
    The American journal of physiology, 1995, Volume: 269, Issue:2 Pt 2

    Topics: Animals; Atropine; Baroreflex; Cardiovascular System; Dogs; Heart Rate; Hemodynamics; Hexamethonium;

1995
Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice.
    Molecular endocrinology (Baltimore, Md.), 1994, Volume: 8, Issue:4

    Topics: Adenylyl Cyclases; Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adrenergic beta-

1994
[Effect of 3-month exercise training on daily energy expenditure in formerly obese women with reduced and stable weight].
    Ugeskrift for laeger, 1993, Jun-14, Volume: 155, Issue:24

    Topics: Adrenergic beta-Antagonists; Adult; Body Weight; Energy Metabolism; Exercise; Female; Humans; Obesit

1993
Power spectral analysis of heart rate variability in obese subjects: evidence of decreased cardiac sympathetic responsiveness.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1996, Volume: 20, Issue:9

    Topics: Adrenergic beta-Antagonists; Adult; Body Mass Index; Female; Heart; Heart Rate; Humans; Male; Middle

1996
Interaction of exercise training and clenbuterol on GLUT-4 protein in muscle of obese Zucker rats.
    The American journal of physiology, 1996, Volume: 271, Issue:5 Pt 1

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Body Weight; C

1996
Benidipine induces thermogenesis in brown adipose tissue by releasing endogenous noradrenaline: a possible mechanism for the anti-obesity effect of calcium antagonists.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1999, Volume: 23, Issue:3

    Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Animals; Body Temperature Regulation; Calcium Ch

1999
Effects of different insulin infusion rates on heart rate variability in lean and obese subjects.
    Metabolism: clinical and experimental, 1999, Volume: 48, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; Body Mass Index; Calorimetry, Ind

1999
Effect of diet on fat cell size and hormone-sensitive lipase activity.
    Journal of applied physiology (Bethesda, Md. : 1985), 1999, Volume: 87, Issue:1

    Topics: Adipocytes; Animals; Cell Size; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Sucrose; Fatty Ac

1999
Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits.
    American journal of hypertension, 2000, Volume: 13, Issue:5 Pt 1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Blood Pressure D

2000
No difference in the lipolytic response to beta-adrenoceptor stimulation in situ but a delayed increase in adipose tissue blood flow in moderately obese compared with lean men in the postexercise period.
    Metabolism: clinical and experimental, 2000, Volume: 49, Issue:5

    Topics: Adipose Tissue; Adult; Exercise; Fatty Acids, Nonesterified; Glycerol; Heart Rate; Humans; Hydralazi

2000
Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo.
    The Journal of clinical investigation, 2000, Volume: 106, Issue:3

    Topics: Activity Cycles; Adrenergic beta-Antagonists; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dog

2000
Abnormal insulin and beta-adrenergic modulation of lipoprotein liipase during refeeding after prolonged fasting in the Zucker rat.
    Diabetologia, 2000, Volume: 43, Issue:7

    Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Body Weight; Eating; Fasting; Food Deprivation

2000
The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men.
    Journal of lipid research, 2001, Volume: 42, Issue:4

    Topics: Adipocytes; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atrial Natriuretic Factor; Bio

2001
Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 282, Issue:3

    Topics: Angiotensin II; Animals; Arteries; Arterioles; Blood Pressure; Diabetes Mellitus; Endothelins; Heart

2002
[Insulin secretion and beta-adrenergic blockade in normal subjects, obese subjects and obese diabetics after carbohydrate stimulation].
    Minerva medica, 1979, May-07, Volume: 70, Issue:22

    Topics: Adrenergic beta-Antagonists; Blood Glucose; Diabetes Mellitus; Glucose; Humans; Insulin; Insulin Sec

1979
In-vitro observations on isolated adipose tissue cells from hyperobese subjects.
    Diabetes, 1977, Volume: 26, Issue:7

    Topics: Adipose Tissue; Adult; Cyclic AMP; Epinephrine; Female; Glycerol; Humans; Insulin; Lipid Metabolism;

1977
The effect of fasting on the adrenergic receptor activity of human adipocytes.
    The Journal of laboratory and clinical medicine, 1979, Volume: 94, Issue:3

    Topics: Adipose Tissue; Cyclic AMP; Epinephrine; Fasting; Humans; In Vitro Techniques; Lipid Metabolism; Obe

1979
Angina pectoris: an overview.
    Angiology, 1977, Volume: 28, Issue:3

    Topics: Angina Pectoris; Angina Pectoris, Variant; Arterial Occlusive Diseases; Blood Pressure; Coronary Art

1977
[Some aspects of the dynamic behavior of IRI in obesity and in diabetes mellitus].
    Minerva medica, 1979, May-12, Volume: 70, Issue:23

    Topics: Adult; Aged; Aminophylline; Antigens; Blood Glucose; Diabetes Mellitus; Female; Glucagon; Glucose; G

1979
The effects of beta adrenergic blockade on basal metabolism and peripheral thyroid metabolism.
    The Proceedings of the Nutrition Society, 1979, Volume: 38, Issue:2

    Topics: Adult; Basal Metabolism; Energy Intake; Humans; Middle Aged; Obesity; Propranolol; Thyroid Gland; Th

1979
Growth hormone response to propranolol and L--dopa in obese subjects.
    Metabolism: clinical and experimental, 1978, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Female; Growth Hormone; Humans; Kinetics; Levodopa; Male; Middle Aged; Obesity; P

1978
[Somatotropic response to a propranolol-glucagon test].
    Minerva pediatrica, 1976, May-12, Volume: 28, Issue:17

    Topics: Child; Glucagon; Growth Disorders; Growth Hormone; Humans; Hypothyroidism; Obesity; Pituitary Gland;

1976
Metabolic effects of increased caloric intake in man.
    Metabolism: clinical and experimental, 1975, Volume: 24, Issue:4

    Topics: Adult; Blood Glucose; Body Weight; Cholesterol; Diet; Eating; Epinephrine; Fasting; Female; Glucose;

1975
The office management of hypertension.
    Angiology, 1975, Volume: 26, Issue:1 Pt. 1

    Topics: Adult; Age Factors; Ambulatory Care; Antihypertensive Agents; Benzothiadiazines; Black or African Am

1975
[Effect of L-dopa and propranolol administration on GH secretion in essential obesity in women].
    Revista clinica espanola, 1975, Jun-30, Volume: 137, Issue:6

    Topics: Administration, Oral; Adult; Aged; Female; Growth Hormone; Humans; Injections, Intravenous; Levodopa

1975
[Influence of propranolol on daily variations in blood cortisol in essential obestiy].
    Bollettino della Societa italiana di biologia sperimentale, 1975, Apr-15, Volume: 51, Issue:7

    Topics: Adolescent; Adrenal Cortex; Adrenal Glands; Adult; Circadian Rhythm; Female; Humans; Hydrocortisone;

1975
Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists.
    Brain research, 1992, Aug-07, Volume: 587, Issue:2

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Clonidine; Dose-Response Relationship, Drug; Drug Inte

1992
Ethnic differences in sympathetic nervous system-mediated energy expenditure.
    The American journal of physiology, 1991, Volume: 261, Issue:6 Pt 1

    Topics: Adrenergic beta-Antagonists; Adult; Basal Metabolism; Energy Metabolism; Fasting; Humans; Indians, N

1991
Effects of central injection of glucose on thermogenesis in normal, VMH-lesioned and genetically obese rats.
    Brain research, 1991, Apr-26, Volume: 547, Issue:1

    Topics: Animals; Blood Glucose; Body Temperature Regulation; Dose-Response Relationship, Drug; Glucose; Inje

1991
Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women.
    International journal of obesity, 1991, Volume: 15, Issue:5

    Topics: Administration, Oral; Adult; Blood Glucose; Blood Pressure; Catecholamines; Epinephrine; Fatty Acids

1991
[Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects].
    Bulletin de l'Academie nationale de medecine, 1990, Volume: 174, Issue:7

    Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Female; Humans; Male; Obesity; Propanolamines; Propr

1990
T3 plus high doses of beta-blockers: effects on energy intake, body composition, bat and heart in rats.
    International journal of obesity, 1990, Volume: 14, Issue:12

    Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Antagonists; Animals; Atenolol; Body Composit

1990
[Selected hemodynamic parameters in overweight patients with mild and moderate hypertension treated with low caloric diet].
    Polskie Archiwum Medycyny Wewnetrznej, 1991, Volume: 85, Issue:3

    Topics: Adult; Diet, Reducing; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Obesity; Propr

1991
Increased alpha 2-adrenergic binding sites and antilipolytic effect in adipocytes from genetically obese rats.
    Journal of lipid research, 1990, Volume: 31, Issue:5

    Topics: Adipose Tissue; Animals; Binding Sites; Brimonidine Tartrate; Dioxanes; Epinephrine; Idazoxan; Kinet

1990
Regulation of brown adipose tissue thermogenesis by corticosterone in obese fa/fa rats.
    International journal of obesity, 1985, Volume: 9 Suppl 2

    Topics: Adipose Tissue, Brown; Adrenalectomy; Aldosterone; Animals; Body Temperature Regulation; Body Weight

1985
The regulation of adenylate cyclase in liver membranes of lean and obese mice.
    Molecular and cellular endocrinology, 1988, Volume: 59, Issue:3

    Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Cell Membrane; Cholera Toxin; Enzyme Activation

1988
Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers.
    Journal of clinical pharmacology, 1987, Volume: 27, Issue:11

    Topics: Adult; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Obesity; Propranolol

1987
Serum somatomedin activity and growth hormone level in obese men: dependence on degree of obesity and hyperlipidemia.
    Experimental and clinical endocrinology, 1986, Volume: 88, Issue:3

    Topics: Adult; Body Weight; Growth Hormone; Humans; Hyperlipidemias; Levodopa; Male; Middle Aged; Obesity; P

1986
Hypothalamic control of brown adipose tissue in Zucker lean and obese rats. Effect of electrical stimulation of the ventromedial nucleus and other hypothalamic centres.
    Brain research, 1987, Mar-10, Volume: 405, Issue:2

    Topics: Adipose Tissue, Brown; Animals; Body Temperature; Efferent Pathways; Electric Stimulation; Female; H

1987
A comparison of the pharmacokinetics of propranolol in obese and normal volunteers.
    British journal of clinical pharmacology, 1986, Volume: 21, Issue:5

    Topics: Administration, Oral; Adult; Biological Availability; Body Weight; Female; Half-Life; Humans; Infusi

1986
Dietary thermogenesis in obesity. Response to carbohydrate and protein meals: the effect of beta-adrenergic blockade and semistarvation.
    International journal of obesity, 1986, Volume: 10, Issue:5

    Topics: Calorimetry; Dietary Carbohydrates; Dietary Proteins; Energy Intake; Energy Metabolism; Female; Huma

1986
Fat and lean chickens: prefattening period and in vivo sensitivity to insulin, atropine, and propranolol.
    The American journal of physiology, 1985, Volume: 249, Issue:4 Pt 2

    Topics: Adipose Tissue; Animals; Atropine; Blood Glucose; Body Weight; Chickens; Diet; Fasting; Food; Glucos

1985
Glucose-induced thermogenesis and insulin resistance in man.
    International journal of obesity, 1985, Volume: 9 Suppl 2

    Topics: Adult; Basal Metabolism; Body Temperature Regulation; Body Weight; Diabetes Mellitus; Diabetes Melli

1985
Regulation of sympathetic activity in lean and obese Zucker (fa/fa) rats.
    The American journal of physiology, 1985, Volume: 249, Issue:3 Pt 1

    Topics: Acclimatization; Adipose Tissue, Brown; Adrenalectomy; Animals; Body Temperature Regulation; Cold Te

1985
Letter: Enhancement of levodopa-induced growth-hormone stimulation by practolol.
    Lancet (London, England), 1974, Nov-30, Volume: 2, Issue:7892

    Topics: Drug Synergism; Growth Hormone; Humans; Levodopa; Obesity; Practolol; Propranolol; Stimulation, Chem

1974
Reappraisal of the role of insulin in hypertriglyceridemia.
    The American journal of medicine, 1974, Volume: 57, Issue:4

    Topics: Administration, Oral; Adult; Aged; Blood Glucose; Diet; Epinephrine; Female; Glucose; Glucose Tolera

1974
[Six years' experience with a musculoplastic technic].
    The Journal of endocrinology, 1971, Volume: 51, Issue:1

    Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists

1971
Cyclic adenosine monophosphate in human adipose tissue.
    Proceedings of the Royal Society of Medicine, 1972, Volume: 65, Issue:9

    Topics: Acetanilides; Adenylyl Cyclases; Adipose Tissue; Adrenal Glands; Adrenergic beta-Antagonists; Amino

1972
The effect of a -adrenergic blocker on insulin release from the isolated perfused pancreas of obese mice.
    The Journal of endocrinology, 1972, Volume: 55, Issue:1

    Topics: Animals; Depression, Chemical; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of L

1972
The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor.
    The Journal of clinical investigation, 1973, Volume: 52, Issue:4

    Topics: Blood Glucose; Diabetes Mellitus; Glucose; Humans; Insulin; Isoproterenol; Obesity; Propranolol; Rec

1973
Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects.
    Diabetes, 1973, Volume: 22, Issue:7

    Topics: Adult; Blood Glucose; Diabetes Mellitus; Epinephrine; Female; Glucose; Glucose Tolerance Test; Human

1973
Effects of propranolol on HGH secretion after endovenous tolbutamide load in obese subjects.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1973, Volume: 5, Issue:6

    Topics: Adult; Aged; Blood Glucose; Fatty Acids, Nonesterified; Growth Hormone; Humans; Middle Aged; Obesity

1973
Catecholamines and obesity, fasting and the adrenergic system.
    Endokrinologie, 1973, Volume: 62, Issue:2

    Topics: Blood Glucose; Catecholamines; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Humans; Ket

1973
[Effect of propranolol on the function of the hypothalamo-pituitary-adrenal system in normal and obese subjects during insulin test of hypoglycemia].
    Archivio "E. Maragliano" di patologia e clinica, 1973, Volume: 29, Issue:1

    Topics: Adolescent; Adult; Blood Glucose; Female; Humans; Hypothalamo-Hypophyseal System; Insulin; Male; Mid

1973
Growth hormone and cortisol secretion after propranolol--glucagon testing in the adult.
    Metabolism: clinical and experimental, 1974, Volume: 23, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Glucose; Female; Glucagon; Growth Hormone; Huma

1974
Plasma growth hormone in hyperthyroidism and obesity: effect of propranolol infusion.
    Metabolism: clinical and experimental, 1970, Volume: 19, Issue:6

    Topics: Blood Glucose; Fatty Acids, Nonesterified; Growth Hormone; Humans; Hyperthyroidism; Obesity; Propran

1970
The role of starvation, hypoglycemia, and adrenergic blockade on growth hormone secretion in obesity.
    Journal of surgical oncology, 1970, Volume: 2, Issue:3

    Topics: Adult; Catecholamines; Fasting; Female; Growth Hormone; Humans; Hypoglycemia; Injections, Intravenou

1970
[The effects of appetitie depressants on fat and carbohydrate metabolism].
    Wiener klinische Wochenschrift, 1971, Jun-11, Volume: 83, Issue:23

    Topics: Acetates; Appetite Depressants; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus; Germany,

1971
[Risk factors, prognosis, treatment and rehabilitation in myocardial infarct].
    Der Landarzt, 1967, Aug-31, Volume: 43, Issue:24

    Topics: Adult; Age Factors; Aged; Angina Pectoris; Anticoagulants; Cholesterol; Female; Humans; Hypertension

1967